Signant Health Appoints Specialist Physician and Clinical Research Expert Dr. Graham C. Ellis as Clinical Vice President to Strengthen Metabolic Disease and Diabetes Trial Capabilities [Ya...
Thermo Fisher Scientific Inc (TMO)
Last thermo fisher scientific inc earnings: 4/22 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.thermofisher.com/investors/investor-overview/default.aspx
Company Research
Source: Yahoo! Finance
Graham C. Ellis as Clinical Vice President. With more than 25 years of experience as a specialist physician and clinical researcher in diabetes, endocrinology, and metabolic disease, Dr. Ellis brings extensive scientific depth and a distinguished track record as a Principal Investigator across more than 150 international Phase 2–4 clinical trials. His appointment strengthens Signant's capabilities in supporting sponsors developing treatments in metabolic disease, obesity, and related therapeutic areas. Dr. Graham C. Ellis - Clinical Vice President, Signant Health "I have spent my career at the intersection of clinical medicine and drug development, where the quality of scientific evidence directly shapes patient outcomes," said Dr. Ellis. "Signant's focus on rigorous evidence generation and its deep operational expertise in clinical outcome assessments make it uniquely positioned to support sponsors in complex therapeutic areas like diabetes and metabolic disease. I look forward t
Show less
Read more
Impact Snapshot
Event Time:
TMO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMO alerts
High impacting Thermo Fisher Scientific Inc news events
Weekly update
A roundup of the hottest topics
TMO
News
- Thermo Fisher Scientific Introduces the Gibco™ CTS™ Compleo™ Fill and Finish System to Help Streamline Cell Therapy Manufacturing [Yahoo! Finance]Yahoo! Finance
- [Latest] Global Environmental Mass Spectrometry Market Size/Share Worth USD 6.47 Billion by 2035 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) [Yahoo! FinanceLatest
- ?????????????:2026???2036???????? [CNET News]CNET News
- Thermo Fisher Scientific Launches Integrated Platform to Accelerate Biologics Development [Yahoo! Finance]Yahoo! Finance
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 23, 2026Business Wire
TMO
Earnings
- 1/29/26 - Beat
TMO
Sec Filings
- 3/31/26 - Form 4
- 3/31/26 - Form 4
- 3/31/26 - Form 4
- TMO's page on the SEC website